JHP Pharmaceuticals, located in Parsippany, New Jersey, is an integrated specialty healthcare company that specializes in sterile injectable products. JHP manufactures and sells brand aseptic injectable pharmaceuticals in hospital and clinical settings and provides contract manufacturing services for global pharmaceutical companies. JHP's own product portfolio includes leading diagnostic, women's health and anesthesia products. All products have a long track record of "gold standard" service and are at or near the front line of treatment in their therapeutic indications. Contract manufactured products include some of the leading global biologic products which involve liquid, lyophilized and suspension presentations.

Learn More
 

JHP Announces FDA Approval for Dantrium IV, Rapidly Mixing In 20 Seconds
        
JHP has developed and received approval by the FDA for Dantrium® IV (dantrolene sodium for injection), a rapidly mixing product.

NDC: 42023-123-06
For additional information visit www.dantrium.com


Read Full Press Release

 

 

 
Latest News
 

10.31.09
JHP’s Brevital® Sodium C-IV (methohexital for injection) Lyophilize Powder, 2.5g
DC: 42023-106-01
Available through the wholesalers
and distributors

For more information on Brevital® Sodium C-IV, please visit www.brevital.com

Learn More

8.28.09
JHP announces the re-launch of Dantrium Capsules 50mg effective August 28th 2009

DC:
42023-125-01
OLD NDC:
0149-0031-05

Strength:
50mg
Pack Size:
100 Capsules

Learn More

 

 
 
 
 
Home  |  About The Company  |  Press Releases & News  |  Products  |  Manufacturing Services  |  Careers  |  Request Information  |  Contact Us  
 

Terms Of Service  |  Privacy Policy  |  Site Map

© JHP Pharmaceuticals. All Rights Reserved. Website Design by Sixty Five Design